Interview with Dr. Mohamed Al-Shaarawi, Sales Director, Pharmaceutical Solutions Industry, Jeddah

JEDDAH, Saudi Arabia - Feb. 2, 2020 - PRLog -- Interview with Dr. Mohamed A. Al-Shaarawi, Sales Director, Pharmaceutical Solutions Industry, Jeddah, Saudi Arabia.

Give us a brief about your participation at Arab Health 2020.

We were happy to meet a great number of key executives and representatives from reputed companies and visitors at the Arab Health in four days. Moreover, we feel happy to be a continuous participant in this largest healthcare exhibition & conferences in the Middle East. In fact, our participation at the show opened new opportunities for us, and following up those leads, the real challenge ahead is to turn them to customers by evaluating their interests and our capacities to meet their requirements.

What are your expectations at the Arab Health 2020?

In order to widen our customer base in local as well as international markets, we are continuously enhancing our product portfolio and looking for more business opportunities beyond GCC and MENA markets.

How significant is for your company to participate at Arab Health 2020?

Every year, our participation at Arab Health benefits in many ways. Obviously, we get opportunity to exhibit our full range of products, meet potential delegates from the healthcare industry, interact with key exhibitors for business cooperation, access newer markets and explore innovative technologies that can enable us to expand our production capacities and efficiently deliver products.

'Connectivity for better healthcare delivery' is the theme of Arab Health 2020. In what ways PSI can contribute its role on the delivery of healthcare?

As the leading, largest producer of a wide range of sterile IV solutions and healthcare provider in the MENA region, PSI, with its expanding product portfolio, aims to fulfil to the needs of both domestic and worldwide markets. With over 40 years, we have remained truly committed to our goals—now that, we are proud to say that PSI has served over one billion patients in the MENA region

To provide utmost benefit for patients, we always remain accessible to meet the needs of the healthcare delivery system. We cherish our vision, which is dear to us. We are happy that while we work sincerely, we even realize that we have to work with honest passion to serve patients worldwide.

ABOUT PSI

PSI, a member of Ambah Group is the leading sterile injectable manufacturer in the MENA. Its manufacturing facilities in Saudi Arabia are GMP certified and equipped with the latest production technologies with over 40 years of proven reliable experience worldwide in contract manufacturing of parenteral solutions in plastic and glass bottles, plastic bags, as well as plastic ampoules. Ambah/PSI has developed the first Ibuprofen intravenous (IV) infusion in the world (400mg/100ml), which is registered as Ambaprofen and Ambafen. Visit us at www.psiltd.com